We are live on !
Find out more
Rangeley Capital Portfolio holdings
AUM
$109M
Turnover
49.06%
1-Year Est. Return
97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
(+6.3%)
Cap. Flow
-$6.26M
Cap. Flow % of AUM
Cap. Flow %
-5.72%
Top 10 Holdings %
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.3
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomad Foods
NOMD
|
+$1.34M |
| 2 |
Mountain Lake Acquisition Corp II
MLAA
|
+$1.27M |
| 3 |
Distribution Solutions Group
DSGR
|
+$1.26M |
| 4 |
enGene Therapeutics
ENGN
|
+$1.24M |
| 5 |
Abivax
ABVX
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$8.47M |
| 2 |
Leggett & Platt
LEG
|
+$2.1M |
| 3 |
Icon
ICLR
|
+$1.96M |
| 4 |
Kezar Life Sciences
KZR
|
+$1.8M |
| 5 |
Mister Car Wash
MCW
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.11% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Financials | 12.51% |
| 4 | Miscellaneous | 10.11% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Rezolute
RZLT
$369M
| $102K | 0.09% |
19,650
-20,350
| -51% | -$75.6K |
2025 Q4
2 quarters
|
|
152
Dingdong
DDL
$433M
| $96.5K | 0.09% |
50,000
| – | – |
2026 Q1
1 quarter
|
|
153
Acumen Pharmaceuticals
ABOS
$164M
| $93.4K | 0.09% |
35,000
| – | – |
2026 Q1
1 quarter
|
|
154
ZoomInfo Technologies
GTM
$1.24B
| $87.9K | 0.08% |
+30,000
| New | +$135K |
2026 Q2
0 quarters
|
|
|
KRSA
155
Korsana Biosciences, Inc. Common Stock
KRSA
$1.46B
| $82.4K | 0.08% |
+3,473
| New | +$78.9K |
2026 Q2
0 quarters
|
|
|
YARW
156
Yarrow Bioscience
YARW
$169M
| $73.6K | 0.07% |
2,261
-100
| -4% | -$3.24K |
2025 Q3
3 quarters
|
|
157
Grace Therapeutics
GRCE
$38.1M
| $59K | 0.05% |
+26,000
| New | +$71.9K |
2026 Q2
0 quarters
|
|
158
Sable Offshore Corp
SOC
$601M
| $58.5K | 0.05% |
19,000
| – | – |
2025 Q2
4 quarters
|
|
159
SITE Centers
SITC
$195M
| $55.6K | 0.05% |
14,000
| – | – |
2024 Q4
6 quarters
|
|
160
Great Elm Capital Corp
GECC
$65.3M
| $54.5K | 0.05% |
10,000
| – | – |
2026 Q1
1 quarter
|
|
161
Invivyd
IVVD
$174M
| $51.5K | 0.05% |
59,000
+14,000
| +31% | +$17.6K |
2026 Q1
1 quarter
|
|
162
Kyivstar Group Warrant
KYIVW
$36M
| $48.5K | 0.04% |
+3,000
| New | +$15.1K |
2026 Q2
0 quarters
|
|
163
TaskUs
TASK
$782M
| $46.8K | 0.04% |
10,000
| – | – |
2025 Q4
2 quarters
|
|
164
DELISTED
Origin Materials
ORGN
| $45.1K | 0.04% |
+45,520
| New | +$74.1K |
2026 Q2
0 quarters
|
|
165
CALL
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$146M
| $44.4K | 0.04% |
+14,200
| New | +$47.5K |
2026 Q2
0 quarters
|
|
166
Werewolf Therapeutics
HOWL
$47.7M
| $36K | 0.03% |
+100,000
| New | +$60.9K |
2026 Q2
0 quarters
|
|
167
Spring Valley Acquisition Corp IV
SVIV
$309M
| $32.9K | 0.03% |
+3,233
| New | +$32.5K |
2026 Q2
0 quarters
|
|
168
Health Catalyst
HCAT
$123M
| $31.6K | 0.03% |
+15,880
| New | +$22.9K |
2026 Q2
0 quarters
|
|
169
M3-Brigade Acquisition VI Corp Units
MBVIU
| $30K | 0.03% |
+2,927
| New | +$29.8K |
2026 Q2
0 quarters
|
|
170
Network-1 Technologies
NTIP
$35.7M
| $29.4K | 0.03% |
+20,000
| New | +$29.3K |
2026 Q2
0 quarters
|
|
171
Optimum Communications Inc
OPTU
$277M
| $29K | 0.03% |
+20,000
| New | +$24.9K |
2026 Q2
0 quarters
|
|
172
Space Asset Acquisition Corp
SAAQ
$316M
| $26.6K | 0.02% |
+2,604
| New | +$26.8K |
2026 Q2
0 quarters
|
|
173
Perimeter Acquisition Corp I
PMTR
$322M
| $26.1K | 0.02% |
+2,502
| New | +$25.9K |
2026 Q2
0 quarters
|
|
174
Evolution Global Acquisition Corp Units
EVOXU
$179M
| $20.6K | 0.02% |
+2,022
| New | +$20.6K |
2026 Q2
0 quarters
|
|
175
Yorkville Acquisition Corp
MCGA
$245M
| $20.6K | 0.02% |
+2,016
| New | +$20.5K |
2026 Q2
0 quarters
|
|
Similar funds
S2L
Rangeley Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.
- Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
- Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
- Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
- Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
- Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
- Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
- Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.
Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.